돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1428264생성일: 2026년 10월 26일

Hydrochloric Acid → Nilotinib Hydrochloride Anhydrous

https://huagongshe.com/reaction/1428264

반응식

참여 물질

역할이름HCID투입량
반응물Hydrochloric AcidHCID 313—
반응물NilotinibHCID 644241—
용매EthanolHCID 702—
생성물Nilotinib Hydrochloride AnhydrousHCID 16006490—

반응 조건

온도5 °C

반응 단계

Nilotinib HCl form T18 as used in any of the processes described in the present application may be prepared according to WO 2010/054056, examples 33-38, which is incorporated herein by reference. For example: To a 1 Liter reactor was added Nilotinib-base form A (20 g, 0.04 mol), absolute ethanol (188 ml) and 13.77% HCl solution in ethanol abs. (10 g, 0.04 mol). The slurry formed thereby was heated to reflux, and dissolution occurred during the stirring. The solution was then filtered under reduced pressure. The filtrate was fed back to the reactor and heated back to reflux. At 76.6° C. the solution was seeded with 0.2 g of dry material obtained by the process of example 23. Precipitation was observed. Then, the solution was maintained at reflux for 1 h, followed by cooling over 2 h to 6° C. At 6° C. ethanol abs. was added (300 ml) and the slurry was stirred at 5° C. for 30 minutes, filtered, washed with ethanol abs. to yield Nilotinib-HCl, form T18.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08937082B2
출처 데이터셋uspto-grants-2015_01
ORD IDord-b0fc258ed38946c29f720d665d43e19c
출처 메모uspto-grants-2015_01